PCVX.NASDAQVaxcyte, INC

Form 4: Vaxcyte SVP Finance Disposes Shares for Tax Obligations

Sentiment:

Insider Transaction Report

📋All filings for Vaxcyte, INC
🔒Login to Follow

Vaxcyte's SVP of Finance, Elvia Cowan, disposed of common stock to cover tax withholding obligations related to RSU vesting.

Summary

  • Elvia Cowan, the Senior Vice President of Finance at Vaxcyte, Inc. (PCVX), reported transactions involving the company's common stock.
  • On September 2, 2025, a total of 567 shares of Vaxcyte common stock were disposed of in two separate transactions (242 shares and 325 shares).
  • These shares were surrendered to Vaxcyte, Inc. to cover applicable tax withholding obligations realized upon the vesting of Restricted Stock Units (RSUs).
  • The disposition price for both transactions was $31.56 per share.
  • Following these reported transactions, Elvia Cowan directly beneficially owns 26,638 shares of Vaxcyte, Inc. common stock.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction for tax purposes related to RSU vesting, which is a common and expected event for executive compensation and does not indicate a discretionary sale or significant change in company outlook.

Positives

  • The vesting of Restricted Stock Units (RSUs) for the SVP of Finance indicates the realization of executive compensation.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • Disposition of common stock to the issuer (Vaxcyte, Inc.) to satisfy tax withholding obligations upon RSU vesting, a standard related-party transaction for executive compensation.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes.
  • Employees: Indicates the realization of compensation for the SVP of Finance through RSU vesting.

Key Dates

DateDescription
09/02/2025Transaction Date for the disposition of common stock to cover tax withholding obligations.
09/04/2025Signature Date of the reporting person's attorney-in-fact on the filing.

Recommendation

hold

The filing details a routine insider transaction where the SVP of Finance disposed of shares to cover tax withholding obligations upon RSU vesting. This is a common and expected event for executive compensation and does not reflect a discretionary sale or provide new material information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as this event is neutral to the company's fundamentals.

Keywords

Vaxcyte, PCVX, Form 4, Insider Transaction, Stock Disposition, RSU Vesting, Tax Withholding, Elvia Cowan, Biotechnology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.